Article in Molecules (Basel, Switzerland), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registry
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what money
Authors and funding
10 authors.
Rocío OteroIgnacio Ribas Research Laboratory, Department of Organic Chemistry, University of Santiago de Compostela, 15782 Santiago de Compostela, Spain.
Samuel SeoaneDepartment of Physiology-Center for Research in Molecular Medicine and Chronic Diseases (CIMUS), University of Santiago de Compostela, 15707 Santiago de Compostela, Spain.
Xoán Fernández-DomínguezIgnacio Ribas Research Laboratory, Department of Organic Chemistry, University of Santiago de Compostela, 15782 Santiago de Compostela, Spain.
Maxime BourguetLaboratoire de Spectrométrie de Masse BioOrganique, Université de Strasbourg, CNRS, IPHC UMR 7178, 67037 Strasbourg, France.
Sarah CianféraniLaboratoire de Spectrométrie de Masse BioOrganique, Université de Strasbourg, CNRS, IPHC UMR 7178, 67037 Strasbourg, France.ORCID 0000-0003-4013-4129
Carole Peluso-IltisInstitut de Génétique et de Biologie Moléculaire et Cellulaire (IGBMC), Université de Strasbourg, CNRS, Inserm, UMR 7104-UMR-S 1258, 67400 Strasbourg, France.
Miguel A MaestroDepartamento de Química-CICA, Universidad de A Coruña, 15071 A Coruña, Spain.ORCID 0000-0001-8922-8033
Román Pérez-FernándezDepartment of Physiology-Center for Research in Molecular Medicine and Chronic Diseases (CIMUS), University of Santiago de Compostela, 15707 Santiago de Compostela, Spain.
Natacha RochelInstitut de Génétique et de Biologie Moléculaire et Cellulaire (IGBMC), Université de Strasbourg, CNRS, Inserm, UMR 7104-UMR-S 1258, 67400 Strasbourg, France.ORCID 0000-0002-3573-5889
Antonio MouriñoIgnacio Ribas Research Laboratory, Department of Organic Chemistry, University of Santiago de Compostela, 15782 Santiago de Compostela, Spain.
Funding
Agence Nationale de la Recherche ANR-10-INBS-08-03Agence Nationale de la Recherche ANR-21-CE17-0009FEDER/Ministerio de Ciencia, Innovación y Universidades-Agencia Estatal de Investigación PID2021-127394OB-100
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.
Synthesis, Molecular Docking and Biological Evaluation of A-Ring-Carborane-Vitamin D Analogues. · full record | OpenQuestion